Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine in Heart Failure Patients
NCT07394270Phase 2Not yet recruiting
- Sponsor
- German University in Cairo
- Start
- Feb 2026
- Primary completion
- Mar 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in heart failure (HF), sponsored by German University in Cairo. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
arginine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07394270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07394270.